Chemistry Reference
In-Depth Information
[27] Joshi, M.,
et al
., Discovery of low-molecular-weight ligands for the AF6 PDZ domain.
Angew
Chem Int Ed
, 2006,
45
, 3790-3795.
[28] Congreve, M.,
et al
., Application of fragment screening by X-ray crystallography to
the discovery of aminopyridines as inhibitors of beta-secretase.
J Med Chem
, 2007,
50
,
1124-1132.
[29] Huth, J. R.,
et al
., Discovery and design of novel hsp90 inhibitors usingmultiple fragment-based
design strategies.
Chem Biol Drug Des
, 2007,
70
, 1-12.
[30] Geschwindner, S.,
et al
., Discovery of a novel warhead against beta-secretase through
fragment-based lead generation.
J Med Chem
, 2007,
50
, 5903-5911.
[31] Edwards, P. D.,
et al
., Application of fragment-based lead generation to the discovery of novel,
cyclic amidine beta-secretase inhibitors with nanomolar potency, cellular activity and high
ligand efficiency.
J Med Chem
, 2007,
50
, 5912-5925.
[32] Shuker, S. B.,
et al
., Discovering high-affinity ligands for proteins: SAR by NMR.
Science
,
1996,
274
, 1531-1534.
[33] Hajduk, P. J.,
et al
., Discovery of potent nonpeptide inhibitors of stromelysin using SAR by
NMR.
J Am Chem Soc
, 1997,
119
, 5818-5827.
[34] Pellecchia, M.,
et al
., NMR-based structural characterization of large protein-ligand interac-
tions.
J Biomol NMR
, 2002,
22
, 165-173.
[35] Jahnke, W.,
et al
., Second-site NMR screening and linker design.
Curr Top Med Chem
, 2003,
3
, 69-80.
[36] Liu, G.,
et al
., Fragment screening and assembly: a highly efficient approach to a selective and
cell active protein tyrosine phosphatase 1B inhibitor.
J Med Chem
, 2003,
46
, 4232-4235.
[37] Wyss, D. F.,
et al
., Non-peptidic small-molecule inhibitors of the single-chain hepatitis C virus
NS3 protease/NS4A cofactor complex discovered by structure-based NMR screening.
J Med
Chem
, 2004,
47
, 2486-2498.
[38] Raimundo, B. C.,
et al
., Integrating fragment assembly and biophysical methods in the chemical
advancement of small-molecule antagonists of IL-2, an approach for inhibiting protein-protein
interactions.
J Med Chem
, 2004,
47
, 3111-3130.
[39] Howard, N.,
et al
., Application of fragment screening and fragment linking to the discovery
of novel thrombin inhibitors.
J Med Chem
, 2006,
49
, 1346-1355.
[40] Huc, I. and Lehn, J. M., Virtual combinatorial libraries: dynamic generation of molecular and
supramolecular diversity by self-assembly.
Proc Natl Acad Sci USA
, 1997,
94
, 2106-2110.
[41] Congreve, M. S.,
et al
., Detection of ligands from a dynamic combinatorial library by X-ray
crystallography.
Angew Chem Int Ed
, 2003,
42
, 4479-4482.
[42] Hajduk, P. J.,
et al
., NMR-based discovery of lead inhibitors that block DNA binding of the
human papillomavirus E2 protein.
J Med Chem
, 1997,
40
, 3144-3150.
[43] Fejzo, J.,
et al
., The SHAPES strategy: an NMR-based approach for lead generation in drug
discovery.
Chem Biol
, 1999,
6
, 755-769.
[44] Lepre, C. A.,
et al
., Applications of SHAPES screening in drug discovery.
Comb Chem High
Throughput Screen
, 2002,
5
, 583-590.
[45] Jahnke, W.,
et al
., NMR reporter screening for the detection of high-affinity ligands.
Angew
Chem Int Ed
, 2002,
41
, 3420-3423.
[46] Kamionka, M.,
et al
.,
In silico
and NMR identification of inhibitors of the IGF-I and IGF-
binding protein-5 interaction.
J Med Chem
, 2002,
45
, 5655-5660.
[47] Fattorusso, R.,
et al
., Discovery of a novel class of reversible non-peptide caspase inhibitors
via a structure-based approach.
J Med Chem
, 2005,
48
, 1649-1656.
[48] Hajduk, P. J.,
et al
., NMR-based modification of matrix metalloproteinase inhibitors with
improved bioavailability.
J Med Chem
, 2002,
45
, 5628-5639.
[49] Huth, J. R. and Sun, C., Utility of NMR in lead optimization: fragment-based approaches.
Comb Chem High Throughput Screen
, 2002,
5
, 631-643.
